Human Immunodeficiency Virus Testing Among People Who Inject Drugs in Rural West Virginia

被引:3
|
作者
Allen, Sean T. [1 ]
Grieb, Suzanne M. [2 ]
White, Rebecca Hamilton [1 ]
O'Rourke, Allison [3 ]
Kilkenny, Michael E. [4 ]
Jones, Christopher M. [5 ]
Latkin, Carl [1 ]
Sherman, Susan G. [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, 624 N Broadway St,Hampton House,Ste 184, Baltimore, MD 21205 USA
[2] Johns Hopkins Sch Med, Ctr Child & Community Hlth Res, Dept Pediat, Baltimore, MD USA
[3] George Washington Univ, Dept Psychol, Ctr AIDS Res, Washington, DC 20052 USA
[4] Cabell Huntington Hlth Dept, Huntington, WV USA
[5] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA
来源
基金
美国国家卫生研究院;
关键词
People who use drugs; substance use; HIV; HIV testing; UNITED-STATES; SYRINGE EXCHANGE; HIV PREVENTION; CARE; RESIDENCE; DIAGNOSIS; IMPACT; WOMEN; BALTIMORE; MORTALITY;
D O I
10.1093/infdis/jiz598
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Limited research exists on factors associated with human immunodeficiency virus (HIV) testing among people who inject drugs (PWID) in rural America. The purpose of this research is to identify factors associated with rural PWID in Appalachia having not been tested for HIV in the past year. Methods. Cross-sectional data (n = 408) from a 2018 PWID population estimation study in West Virginia were used to examine factors associated with PWID having not been tested for HIV in the past year. Results. Most participants identified as male (61%), white, non-Hispanic (84%), and reported having recently injected heroin (81%) and/or crystal methamphetamine (71%). Most (64%) reported having been tested for HIV in the past year, 17% reported having been tested but not in the past year, and 19% reported never having been tested. In multivariable analysis, not having been in a drug treatment program in the past year was associated with PWID not having been tested for HIV in the past year (adjusted prevalence ratio, 1.430; 95% confidence interval, 1.080-1.894). Conclusions. Drug treatment programs may be important venues for rural PWID to access HIV testing; however, testing services should be offered at multiple venues as most PWID had not engaged in drug treatment in the past year.
引用
收藏
页码:S346 / S353
页数:8
相关论文
共 50 条
  • [21] Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon
    Spencer, Hunter C.
    Babiarz, Jane
    Menza, Tim W.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2023, 34 (08) : 567 - 573
  • [22] Measures of human immunodeficiency virus (HIV) community viral load and HIV incidence among people who inject drugs
    Glasheen, Cristie
    Johnson, Eric O.
    Lorvick, Jennifer
    Kral, Alex H.
    ANNALS OF EPIDEMIOLOGY, 2018, 28 (01) : 8 - 12
  • [23] Human immunodeficiency virus infection and related risk behavior in people who inject drugs in Nepal
    Kakchapati, Sampurna
    Singh, Dipendra Raman
    Rawal, Bir Bahadhur
    Lim, Appiradee
    ASIAN BIOMEDICINE, 2016, 10 (06) : 609 - 617
  • [24] A qualitative exploration of barriers and facilitators to drug treatment services among people who inject drugs in West Virginia
    Abigail K. Winiker
    Kristin E. Schneider
    Rebecca Hamilton White
    Allison O’Rourke
    Suzanne M. Grieb
    Sean T. Allen
    Harm Reduction Journal, 20
  • [25] A qualitative exploration of barriers and facilitators to drug treatment services among people who inject drugs in west Virginia
    Winiker, Abigail K.
    Schneider, Kristin E.
    White, Rebecca Hamilton
    O'Rourke, Allison
    Grieb, Suzanne M.
    Allen, Sean T.
    HARM REDUCTION JOURNAL, 2023, 20 (01)
  • [26] Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan
    Mansha, Sana
    Imran, Muhammad
    Shah, Amir Miraj Ul Hussain
    Jamal, Muhsin
    Ahmed, Fayyaz
    Atif, Muhammad
    Saleem, Muhammmad
    Safi, Sher Zaman
    Fatima, Zareen
    Waqar, Ahmed Bilal
    VIRAL IMMUNOLOGY, 2017, 30 (05) : 366 - 370
  • [27] A Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Munich, Germany, Is Associated With Consumption of Synthetic Cathinones
    Hanke, Kirsten
    Fiedler, Stefan
    Grumann, Christina
    Ratmann, Oliver
    Hauser, Andrea
    Klink, Patrycja
    Meixenberger, Karolin
    Altmann, Britta
    Zimmermann, Ruth
    Marcus, Ulrich
    Bremer, Viviane
    Auwaerter, Volker
    Bannert, Norbert
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (06):
  • [28] Sex Work as an Emerging Risk Factor for Human Immunodeficiency Virus Seroconversion Among People who Inject Drugs in the SurvUDI Network
    Blouin, Karine
    Leclerc, Pascale
    Morissette, Carole
    Roy, Elise
    Blanchette, Caty
    Parent, Raymond
    Serhir, Bouchra
    Alary, Michel
    SEXUALLY TRANSMITTED DISEASES, 2016, 43 (10) : 648 - 655
  • [29] Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus Strains
    Redd, Andrew D.
    Doria-Rose, Nicole A.
    Weiner, Joshua A.
    Nason, Martha
    Seivers, Matthew
    Schmidt, Stephen D.
    Laeyendecker, Oliver
    Martens, Craig
    Bruno, Daniel
    Keele, Brandon F.
    Raju, Nagarajan
    Georgiev, Ivelin S.
    Lamers, Susanna L.
    Astemborski, Jacquie
    Kirk, Gregory D.
    Mascola, John R.
    Ackerman, Margaret E.
    Mehta, Shruti H.
    Quinn, Thomas C.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (05): : 756 - 765
  • [30] Factors Associated with Likelihood of Initiating Others into Injection Drug Use Among People Who Inject Drugs in West Virginia
    Allen, Sean T.
    Schneider, Kristin E.
    Mazhnaya, Alyona
    White, Rebecca Hamilton
    O'Rourke, Allison
    Kral, Alex H.
    Bluthenthal, Ricky N.
    Kilkenny, Michael E.
    Sherman, Susan G.
    AIDS AND BEHAVIOR, 2022, 26 (01) : 47 - 56